Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Giza, 11562, Egypt.
Pediatrics Department, Faculty of Medicine, Cairo University, Giza, Egypt.
J Clin Immunol. 2020 Aug;40(6):820-832. doi: 10.1007/s10875-020-00799-2. Epub 2020 Jun 6.
LPS-responsive beige-like anchor (LRBA) deficiency is an autosomal recessive primary immunodeficiency disorder, OMIM (#614700). LRBA deficiency patients suffer from variable manifestations including recurrent infections, immune dysregulation, autoimmunity, cytopenias, and enteropathy. This study describes different clinical phenotypes and immunological characteristics of 18 LRBA deficiency patients diagnosed from Egypt. T and B lymphocyte subpopulations, LRBA, and cytotoxic T lymphocyte-associated protein 4 (CTLA4) expression were evaluated in resting and stimulated T cells using flow cytometry. Next-generation sequencing was used to identify mutations in the LRBA gene. LRBA deficiency patients had significantly lower B cells and increased percentage of memory T cells. CTLA4 levels were lower in LRBA-deficient T regulatory cells in comparison to healthy donors at resting conditions and significantly increased upon stimulation of T cells. We identified 11 novel mutations in LRBA gene ranging from large deletions to point mutations. Finally, we were able to differentiate LRBA-deficient patients from healthy control and common variable immunodeficiency patients using a simple flow cytometry test performed on whole blood and without need to prior stimulation. LRBA deficiency has heterogeneous phenotypes with poor phenotype-genotype correlation since the same mutation may manifest differently even within the same family. Low LRBA expression, low numbers of B cells, increased numbers of memory T cells, and defective CTLA4 expression (which increase to normal level upon T cell stimulation) are useful laboratory tests to establish the diagnosis of LRBA deficiency. Screening of the siblings of affected patients is very important as patients may be asymptomatic at the beginning of the disease course.
LPS 反应性米色样锚定(LRBA)缺乏症是一种常染色体隐性原发性免疫缺陷病,OMIM(#614700)。LRBA 缺乏症患者表现出多种临床表现,包括反复感染、免疫失调、自身免疫、血细胞减少和肠病。本研究描述了从埃及诊断的 18 例 LRBA 缺乏症患者的不同临床表型和免疫学特征。使用流式细胞术评估静止和刺激 T 细胞中的 T 和 B 淋巴细胞亚群、LRBA 和细胞毒性 T 淋巴细胞相关蛋白 4(CTLA4)表达。下一代测序用于鉴定 LRBA 基因中的突变。LRBA 缺乏症患者的 B 细胞明显减少,记忆 T 细胞比例增加。与健康供体相比,LRBA 缺陷型 T 调节细胞在静止状态下 CTLA4 水平较低,在 T 细胞刺激后显著增加。我们在 LRBA 基因中发现了 11 种新的突变,范围从大片段缺失到点突变。最后,我们能够使用全血进行的简单流式细胞术测试,无需预先刺激,将 LRBA 缺乏症患者与健康对照和常见可变免疫缺陷患者区分开来。LRBA 缺乏症具有异质性表型,表型-基因型相关性差,因为同一突变即使在同一家庭中也可能表现不同。LRBA 表达低、B 细胞数量少、记忆 T 细胞数量增加以及 CTLA4 表达缺陷(T 细胞刺激后增加至正常水平)是建立 LRBA 缺乏症诊断的有用实验室检测。受影响患者的兄弟姐妹筛查非常重要,因为患者在疾病早期可能无症状。